$BMRN News Article - BioMarin Receives Positive CHMP Opinion in Europe to Expand Use of VOXZOGO (vosoritide) to Treat Children Aged 4 Months and Older with Achondroplasia https://marketwirenews.com/news-releases/biom...49087.html
My Twitter: WhyteStocks